Biogen (NASDAQ:BIIB) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $9.15 on revenue of $3.62B. Analysts polled by anticipated EPS of $7.53 on revenue of $3.48B. That compared to EPS of $5.8 on revenue of $3.36B in the same period a year earlier. The company had reported EPS of $6.98 on revenue of $3.49B in the previous quarter.
Biogen follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Novartis ADR earnings beat analysts' expectations on Thursday, with second quarter EPS of $1.34 on revenue of $11.76B. analysts expected EPS of $1.21 on revenue of $11.49B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
